A low-carbohydrate as compared with a low-fat diet in severe obesity

New England Journal of Medicine

Volumn 348, Issue 21, 2003, Pages 2074-2081

  Samaha, Frederick F ^a,b,d   Iqbal, Nayyar ^a,b   Seshadri, Prakash ^b   Chicano, Kathryn L ^a   Daily, Denise A ^a   McGrory, Joyce ^a   Williams, Terrence ^a   Williams, Monica ^a   Gracely, Edward J ^c   Stern, Linda ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d MC 111C ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; FEMALE; HUMAN; INSULIN SENSITIVITY; LIPID DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DIET, FAT-RESTRICTED; DIET, REDUCING; DIETARY CARBOHYDRATES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0038751994     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa022637     Document Type: Article

References (20)

1. StJeor ST, Howard BV, Prewitt TE, Bovee V, Bazzarre T, Eckel RH. Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001;104:1869-74.
2. Kennedy ET, Bowman SA, Spence JT, Freedman M, King J. Popular diets; correlation to health, nutrition, and obesity. J Am Diet Assoc 2001;101:411-20.
3. Westman EC. A review of very low carbohydrate diets for weight loss. J Clin Outcomes Manage 1999;6(7):36-40.
4. Westman EC, Yancy WS, Edman JS, Tomlin KF, Perkins CE. Effect of 6-month adherence to a very low carbohydrate diet program. Am J Med 2002;113:30-6.
5. Natow AB, Heslin J-A. The diabetes carbohydrate & calorie counter. New York: Simon & Schuster, 1991.
6. Eades MR, Eades MD. Protein power lifeplan. New York: Warner Books, 2000:434.
7. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report: executive summary. Obes Res 1998;6:Suppl 2:51S-63S. [Erratum, Obes Res 1998;6:464.]
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
10. Karvetti RL, Knuts LR, Validity of the 24hour dietary recall. J Am Diet Assoc 1985;85:1437-42.
11. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1977.
12. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Norwalk, Conn.: Appleton & Lange, 1990.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
14. Sacks FM, Tonkin AM, Craven T, et al. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycefides as risk factors. Circulation 2002;105:1424-8.
15. Rubin HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410-8.
16. Ginsberg HN. Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer. Ann Intern Med 1997;126:912-4.
17. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.
18. Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 1998;47:1174-9.
19. Stuhlinger MC, Abbasi F, Chu JW, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002;287:1420-6.
20. St-Pierre J, Lemieux I, Vohl MC, et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002;90:15-8.